Dr. Reza Mehrazin, MD
Dr. Reza Mehrazin is an attending at Mount Sinai School of Medicine. He has completed a two-year Society of Urologic Oncology (SUO) accredited fellowship at a highly prestigious National Cancer Institute (NCI) designated cancer center, Fox Chase Cancer Center. Dr. Mehrazin’s clinical expertise is in Robotic surgery, laparoscopic, and open surgical techniques for the treatment of various urologic cancers, which allows him to tailor a specific treatment plan based on individual patient need and preferences. He is one of the few urologists in the region who has extensive training and certified in performing minimally invasive organ preserving and reconstructive techniques to preserve function and quality of life for patients with urologic malignancies. He performs both robotic (using da Vinci® technology) and open cystectomies with continent urinary diversion (new bladder), nephron-sparing (kidney preserving) partial nephrectomy, nerve-sparing prostatectomy, partial or total adrenalectomy, retroperitoneal lymph node dissection for testicular cancer, and endoscopic nephron-sparing management of patients with upper tract urothelial carcinomas. He has authored and co-authored over 200 scientific manuscripts, abstracts, and text book chapters.
- The Mount Sinai Hospital
- Mount Sinai Faculty Practice Associates
- Mount Sinai Beth Israel - Petrie Division
- American Board of Urology
Education and training
- Medical School - Medical University of the Americas – Nevis, Doctor of Medicine
- University of Tennessee, Residency in Urology
- University of Tennessee, Internship in General Surgery
- Fox Chase Cancer Center, Fellowship in Urologic Oncology and Robotic Surgery
- American Urological Association
Awards and publications
- Mehrazin R, Smaldone M, Kutikov A, Li T, Tomazewski J, Canter D, Viterbo R, Greenberg R, Chen D, Uzzo R. Growth Kinetics and Short Term Outcomes of cT1b and cT2 Renal Masses Under Active Surveillance. The Journal of Urology 2014.
- Kopp R, Mehrazin R, Palazzi K, Liss M, Jabaji R, Miheydar H, Lee H, Patterson A, Derweesh I. Survival Outcomes after Radical and Partial Nephrectomy for Clinical T2 Renal Tumors Categorized by RENAL Nephrometry Score. British Journal of Urology International. 2013.
- Mehrazin R, Uzzo R, Kutikov A, Tomaszewski J, Ginzburg S, Ruth K, Al-Saeem E, Abbosh P, Ito T, Chen D, Viterbo R, Greenberg R, Smaldone M, Al-Saleem T. Lymphopenia as an Independent Predictor of Worse Outcome in Papillary Renal Cell Carcinoma. Urologic Oncology 2014.
Mount Sinai Doctors
Mount Sinai Doctors Faculty Practice
5 East 98th Street, 6th Floor
New York, NY 10029